UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

European journal of neurology, 2011-09, Vol.18 (9), p.1122-1131

2011

Volltextzugriff (PDF)

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

Neurological research (New York), 2010-06, Vol.32 (5), p.451-459

2010

Volltextzugriff (PDF)

PO10-TU-53 Botulotoxin A in the treatment of MS related urinary urgency

Journal of the neurological sciences, 2009, Vol.285, p.S210-S210

2009

Volltextzugriff (PDF)

10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial

The Lancet (British edition), 2010-09, Vol.376 (9746), p.1074-1084

2010

Volltextzugriff (PDF)

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-06, Vol.381 (9884), p.2167-2175

2013

Volltextzugriff (PDF)

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.387-401

2010

Volltextzugriff (PDF)

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

The Lancet (British edition), 2008-10, Vol.372 (9648), p.1463-1472

2008

Volltextzugriff (PDF)

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Lancet neurology, 2014-05, Vol.13 (5), p.472-481

2014

Volltextzugriff (PDF)

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial

The Lancet (British edition), 2004-05, Vol.363 (9420), p.1491-1502

2004

Volltextzugriff (PDF)

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Lancet neurology, 2012-05, Vol.11 (5), p.420-428

2012

Volltextzugriff (PDF)

Cognitive Rehabilitation in Patients with Multiple Sclerosis

Česká a Slovenská neurologie a neurochirurgie, 2014-11, Vol.77/110 (6), p.677-683

2014

Volltextzugriff (PDF)

Efficacy results of a study of THC:CBD in central neuropathic pain due to multiple sclerosis

Multiple sclerosis, 2008-09, Vol.14, p.S158-S158

2008

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex ® ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis: Sativex for refractory spasticity in MS

European journal of neurology, 2011-09, Vol.18 (9), p.1122-1131

2011

Volltextzugriff (PDF)

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis

Archives of neurology (Chicago), 2012-10, Vol.69 (10), p.1259

2012

Volltextzugriff (PDF)

Guillain-Barré syndrome: an overview of current concepts

Supplements to Clinical neurophysiology, 2000, Vol.53, p.388-395

Ambler, Z

2000

Volltextzugriff (PDF)

Continuing medical education in Europe-trends and developments

European journal of neurology, 1997-03, Vol.4 (2), p.109-113

1997

Volltextzugriff (PDF)

A465 Project NEMY: Early Diagnostics, Prophylaxis and Treatment of Polyneuropathy in the Patients with MM

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S74-S74

2009

Volltextzugriff (PDF)

Chapter 56 Guilain-Barré syndrome: an overview of current concepts

Supplements to Clinical Neurophysiology, 2000, Vol.53, p.388-395

Ambler, Z.

2000

Volltextzugriff (PDF)

Granulomatous myopathy in patients with sarcoidosis and myasthenia gravis

Ceskoslovenské patologie, 2006-10, Vol.42 (4), p.175-181

2006

Volltextzugriff (PDF)

European Federation of Neurological Societies(EFNS) - approval (co-sponsorship) of Continuing Medical Education (CME) meetings

European journal of neurology, 1999-05, Vol.6 (3), p.259-265

1999

Volltextzugriff (PDF)

European Federation of Neurological Societies(EFNS) — approval (co‐sponsorship) of Continuing Medical Education (CME) meetings: Guidelines developed by the EFNS Task Force for Continuing Medical Education (CME)

European journal of neurology, 1999-05, Vol.6 (3), p.259-265

1999

Volltextzugriff (PDF)

Repetitive afterdischarge in EMG

Electroencephalography and clinical neurophysiology, 1995-11, Vol.95 (5), p.P101-P102

Ambler, Z.

1995

Volltextzugriff (PDF)

EMG findings in polymyositis

Electroencephalography and clinical neurophysiology, 1995-11, Vol.95 (5), p.P102-P102

Ambler, Z.

1995

Volltextzugriff (PDF)

International classification of headache (shortened form)

Ceskoslovenska neurologie a neurochirurgie, 1991-07, Vol.54 (3), p.178

Ambler, Z

1991

Volltextzugriff (PDF)

Diabetic neuropathy. Diagnosis and classification

Ceskoslovenska neurologie a neurochirurgie, 1990-09, Vol.53 (5), p.289

Ambler, Z

1990

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(116)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

PO10-TU-53 Botulotoxin A in the treatment of MS related urinary urgency

10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Cognitive Rehabilitation in Patients with Multiple Sclerosis

Efficacy results of a study of THC:CBD in central neuropathic pain due to multiple sclerosis

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex ® ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis: Sativex for refractory spasticity in MS

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis

Guillain-Barré syndrome: an overview of current concepts

Continuing medical education in Europe-trends and developments

A465 Project NEMY: Early Diagnostics, Prophylaxis and Treatment of Polyneuropathy in the Patients with MM

Chapter 56 Guilain-Barré syndrome: an overview of current concepts

Granulomatous myopathy in patients with sarcoidosis and myasthenia gravis

European Federation of Neurological Societies(EFNS) - approval (co-sponsorship) of Continuing Medical Education (CME) meetings

European Federation of Neurological Societies(EFNS) — approval (co‐sponsorship) of Continuing Medical Education (CME) meetings: Guidelines developed by the EFNS Task Force for Continuing Medical Education (CME)

Repetitive afterdischarge in EMG

EMG findings in polymyositis

International classification of headache (shortened form)

Diabetic neuropathy. Diagnosis and classification

Suchergebnisse filtern